Company intelligence / Profile preview
Audax Medical
Concord, Massachusetts, United Statesaudaxmed.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Audax Medical is a privately held medical technology company focused on nanoscale regenerative biomaterials and licensed nanomolecule technology for development of COVID-19 antiviral therapy; available public information indicates programs are at pre-clinical stage with no reported human trial outcomes yet.[2]
- Therapeutic areas
- RheumatologyOtherInfectious Diseases
- Modalities
- DeviceHydrogel-based drug delivery therapyBiologic
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Northeastern University (license of nanomolecule technology for COVID-19 antiviral therapy)[2]
Beyond the preview
Go deeper on Audax Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Audax Medical.